Vice Provost and Dean of Research
Showing 51-99 of 99 Results
-
William H. Robinson, MD PhD
James W. Raitt, M.D. Professor
Current Research and Scholarly InterestsOur lab investigates the molecular mechanisms of and develops therapies to treat autoimmune and rheumatic diseases, with a focus on rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, and osteoarthritis.
The overriding objectives of our laboratory are:
1. To elucidate the mechanisms underlying autoimmune and rheumatic diseases.
2. To investigate the role of innate immune inflammation in osteoarthritis.
3. To develop novel diagnostics and therapeutics -
Stephen Rock
Professor of Aeronautics and Astronautics, Emeritus
BioProfessor Rock's research interests include the application of advanced control and modeling techniques for robotic and vehicle systems (aerospace and underwater). He directs the Aerospace Robotics Laboratory in which students are involved in experimental programs designed to extend the state-of-the-art in robotic control. Areas of emphasis include planning and navigation techniques (GPS and vision-based) for autonomous vehicles; aerodynamic modeling and control for aggressive flight systems; underwater remotely-operated vehicle control; precision end-point control of manipulators in the presence of flexibility and uncertainty; and cooperative control of multiple manipulators and multiple robots. Professor Rock teaches several courses in dynamics and control.
-
Stanley G. Rockson, MD
Allan and Tina Neill Professor of Lymphatic Research and Medicine
Current Research and Scholarly InterestsMy clinical research includes studies on risk factor modification in atherosclerosis and coronary artery disease; clinical trials involving medical therapies for peripheral arterial insufficiency; coronary angiogenesis; therapy of lymphedema; atherand photodynamic therapy in atherosclerosis.
-
Jonathan Rodden
Professor of Political Science, Senior Fellow at the Hoover Institution and at the Stanford Institute for Economic Policy Research
BioJonathan Rodden is a professor in the political science department at Stanford who works on the comparative political economy of institutions. He has written several articles and three books on federalism and fiscal decentralization. One of those books, "Hamilton’s Paradox: The Promise and Peril of Fiscal Federalism," was the recipient of the Gregory Luebbert Prize for the best book in comparative politics in 2007. He works with institutions including the World Bank, International Monetary Fund, USAID, and the European Parliament on issues related to fiscal decentralization and federalism.
He has also written papers on the geographic distribution of political preferences within countries, legislative bargaining, the distribution of budgetary transfers across regions, and the historical origins of political institutions. He has written a series of papers applying tools from mathematics and computer science to questions about redistricting, culminating in a 2019 book called "Why Cities Lose: The Deep Roots of the Urban-Rural Political Divide" (Basic Books). Rodden has also embarked on an inter-disciplinary collaborative project focused on handgun acquisition.
Rodden received his PhD from Yale University and his BA from the University of Michigan, and was a Fulbright student at the University of Leipzig, Germany. Before joining the Stanford faculty in 2007, he was the Ford Associate Professor of Political Science at the Massachusetts Institute of Technology.
Other Affiliation:
Director of the Spatial Social Science Lab at Stanford -
Seth Rodgers
Senior Licensing Manager, Life Sciences, Office of Technology Licensing (OTL)
BioSeth is an experienced entrepreneur and executive with more than 15 years’ experience in start-up and mid-size life science companies.
Specialties: market analysis, product development, R&D management in life sciences and medical devices. -
Carolyn Rodriguez
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
BioDr. Carolyn Rodriguez is Associate Dean for Academic Affairs, Stanford University School of Medicine and a Consultation-Liaison Psychiatrist at the Palo Alto Veterans Affairs. As the Director of the Stanford OCD Research Lab and Professor in the Department of Psychiatry and Behavioral Sciences, Dr. Rodriguez leads studies investigating the brain basis of severe mental disorders. Her landmark clinical trials pioneer rapid-acting treatments for illnesses including OCD and related disorders. Her NIH-, foundation-, and donor-funded mechanistic and clinical efficacy studies span targeted glutamatergic and opioid pathway pharmacotherapy, noninvasive brain stimulation, psychotherapy and suicide prevention.
Dr. Rodriguez also serves as Deputy Editor of the American Journal of Psychiatry and Deputy Editor of Neuropsychopharmacology. She serves as a member of several scientific councils for non-profit research and advocacy groups including Brain & Behavior Research Foundation, the American Foundation for Suicide Prevention, Orchard OCD and the International OCD Foundation. She has won several national awards, including the Presidential Early Career Award for Scientists and Engineers (PECASE), which recognizes investigators who are pursuing bold and innovative projects, the 2022 Dolores Shockley Mentoring Award from the American College of Neuropsychopharmacology, and the 2025 American Psychiatric Association (APA) Research Mentoring Award.
Carolyn received her B.S. in Computer Science from Harvard University, followed by an M.D. from Harvard Medical School-M.I.T. and a Ph.D. in Neuroscience and Genetics from Harvard Medical School. -
Fatima Rodriguez
Associate Professor of Medicine (Cardiovascular Medicine)
BioFatima Rodriguez, MD, MPH serves as the Vice Chair of Clinical Research (Department of Medicine), Section Chief of Preventive Cardiology, and Associate Director of the Center for Digital Health at Stanford University. She received her medical degree from Harvard Medical School and a Master of Public Health from the Harvard T.H. Chan School of Public Health. Dr. Rodriguez completed her internal medicine residency at Brigham and Women’s Hospital and fellowship in cardiovascular medicine at Stanford.
Dr. Rodriguez specializes in the prevention and management of cardiovascular disease, with clinical expertise in coronary artery disease and inherited lipid disorders. Her research focuses on cardiovascular disease prevention and health promotion, leveraging digital tools to improve guideline-based care, and using AI-enabled approaches for early detection of atherosclerosis. -
Patricia Rodriguez Espinosa
Assistant Professor of Epidemiology and Population Health
BioDr. Patricia Rodriguez Espinosa, PhD., MPH, is an Assistant Professor in the Department of Epidemiology and Population Health and also serves as the Associate Director of Research for the Office of Community Engagement at Stanford Medicine. Dr. Rodriguez Espinosa is also the Associate Core Lead for the Outreach, Recruitment, and Engagement Core of the Stanford Alzheimer's Disease Research Center. The ultimate goal of her research is to improve the health of diverse populations - including Latinxs, under-resourced communities, and older adults - through transdisciplinary and community-engaged scholarship. Her research aims to develop novel multi-level interventions and health promotion programs to improve health outcomes (e.g., around aging, multiple chronic conditions, cardiovascular disease) and that include multi-sectoral collaborations. Dr. Rodriguez Espinosa's research has also centered around developing the science of Community-Based Participatory Research, citizen/community science, and other participatory research approaches.
-
Kacper Rogala
Assistant Professor of Structural Biology and of Chemical and Systems Biology
Current Research and Scholarly InterestsOur team is fascinated by how cells make growth decisions — to grow or not to grow. In order to grow, cells require nutrients, and we are unraveling how cells use specialized protein sensors and transporters to sense and traffic nutrients in between various compartments. We use approaches from structural biology, chemical biology, biophysics, biochemistry, and cell biology — to reveal the mechanisms of basic biological processes, and we develop chemical probes that modulate them.
-
Angela Rogers
Professor of Medicine (Pulmonary and Critical Care)
Current Research and Scholarly InterestsWe use genetics and genomics methodologies to identify novel ARDS pathobiology; we hope that this will enable identification of novel biomarkers, phenotypes, and treatments for the disease. We are building a plasma biobank of critically ill patients at Stanford, with a particular focus on metabolic changes in critical illness.
-
Eugene Y. Roh, MD
Clinical Associate Professor, Orthopaedic Surgery
Current Research and Scholarly InterestsTherapeutic Efficacy of biologic treatments(Platelet Rich Plasma, adipose, mfat, bone marrow, stem cell) in OA and tendonitis
Application of musculoskeletal ultrasound for sports medicine and other musculoskeletal disease.
AI-based musculoskeletal diagnosis and treatment in sports, OA and tendinitis -
Rajat Rohatgi
Professor of Biochemistry and of Medicine (Oncology)
Current Research and Scholarly Intereststhe overall goal of my laboratory is to uncover new regulatory mechanisms in signaling systems, to understand how these mechanisms are damaged in disease states, and to devise new strategies to repair their function.
-
Milenia Rojas Mendoza
Ph.D. Student in Chemical Engineering, admitted Autumn 2022
OTL Intern, Office of Technology Licensing (OTL)BioMilenia Rojas (she/her) is a PhD candidate in the Chemical Engineering Department at Stanford University. She is advised by Thomas Jaramillo. Milenia's research focuses on integrating cost-effective, earth-abundant metal catalysts into membrane electrode assembly water electrolyzers for hydrogen production. Her goal is to reduce production costs, extend lifespan, and enhance scalability to support the energy transition. She is part of the Emerson Consequential Scholars Program and works part time at the office of technology transfer. She graduated in 2022 with a Bachelor's in Chemical Engineering from the University of Rochester.
-
Julie Marie Romero
Industrial Contract Associate, Office of Technology Licensing (OTL)
Current Role at StanfordProject Manager 1 - General, Industry Relations
-
Maria Grazia Roncarolo
George D. Smith Professor of Stem Cell and Regenerative Medicine, Emerita
Current Research and Scholarly InterestsResearch Interests
Immunetolerance: Mechanisms underlying T-cell tolerance, induction of T-cell anergy and regulatory T cells; Immunomodulation: mAbs, proteins and low molecular weight compounds which can modulate T-cell activation; Primary immunodeficiencies: Characterization of molecular and immunological defects; Gene therapy: Gene transduction of hematopoietic cells for gene therapy in primary immunodeficiencies and metabolic diseases; Hematopoiesis: Mechanisms underlying growth and differentiation of hematopoietic stem cells; Transplantation: Immune reconstitution and T-cell tolerance after allogenic stem cell transplantation; Cytokines/Cytokine receptors: Role in regulation of immune and inflammatory responses
Clinical Interests
Primary Immunodeficiencies
Monogenic Autoimmune Disorders
Allogenic Bone Marrow Transplantation
Gene Therapy Clinical Trials
Cell Therapy Clinical Trials
Clinical Trials in Autoimmune Diseases and Organ Transplantation
Clinical Trials in Hemoglobinopathies -
Lisa Goldman Rosas
Associate Professor (Research) of Epidemiology and Population Health, of Medicine (Primary Care and Population Health) and, by courtesy, of Pediatrics
BioLisa Goldman Rosas, PhD MPH is an Associate Professor in the Department of Epidemiology and Population Health and the Department of Medicine, Division of Primary Care and Population Health at Stanford School of Medicine. An epidemiologist by training, Dr. Goldman Rosas’ research focuses on addressing disparities in diet-related chronic diseases such as diabetes, heart disease, depression, and cancer especially for those who face food insecurity. This research features rigorous quantitative and qualitative methodologies, participatory qualitative approaches, and shared leadership with patient and community partners. She is passionate about integrating patients, caregivers, community organizations, and other key stakeholders in the research process in order to affect the greatest improvements in health and well-being. As a reflection of this passion, Dr. Goldman Rosas serves as the Faculty Director for the School of Medicine Office of Community Engagement, Co-Director of Community-Engaged Research for the Office of Cancer Health Equity, and Director of the Outreach, Recruitment and Engagement Core for the Alzheimer's Disease Research Center. In these roles, she supports other faculty and patient and community partners to develop sustainable and meaningful partnerships to support transformative research. In addition to research, she teaches at the undergraduate and graduate levels and has a special focus on increasing capacity in community engagement methods.
-
Christian Rose, MD
Assistant Professor of Emergency Medicine (Adult Clinical/Academic)
Current Research and Scholarly InterestsUncertainty permeates the practice of emergency medicine. I want to answer the question: what do you do when you don't know what to do?
-
Jessica Rose
Professor of Orthopaedic Surgery
Current Research and Scholarly InterestsDr. Rose's research investigates neuromuscular mechanisms underlying cerebral palsy (CP) and early brain and motor development in preterm children. Research examines gait biomechanics as well as neonatal brain microstructure on DTI, physiology and motor function in CP. Dr. Rose served on NIH Taskforce on Childhood Motor Disorders, AACPDM Research Committee, NIH Steering Committee on CDE for CP neuroimaging diagnostics, BOD of SBMT and serves on the IAACD Research Committee.
-
Sherri Rose
Professor of Health Policy and, by courtesy, of Computer Science
BioSherri Rose, Ph.D. is a Professor of Health Policy and, by courtesy, of Computer Science at Stanford University, where she is Director of the Health Policy Data Science Lab. Her research is centered on developing and integrating innovative statistical machine learning approaches to improve human health. Within health policy, Dr. Rose works on algorithms in health care, risk adjustment, chronic kidney disease, and health program evaluation. She has published interdisciplinary projects across varied outlets, including Biometrics, Journal of the American Statistical Association, Journal of Health Economics, Health Affairs, and New England Journal of Medicine. In 2011, Dr. Rose coauthored the first book on machine learning for causal inference, with a sequel text released in 2018.
Dr. Rose has been honored with an NIH Director’s Pioneer Award, NIH Director's New Innovator Award, the ISPOR Bernie J. O'Brien New Investigator Award, and multiple mid-career awards, including the Gertrude M. Cox Award. She is a Fellow of the American Statistical Association (ASA) and received the Mortimer Spiegelman Award, which recognizes the statistician under age 40 who has made the most significant contributions to public health statistics. In 2024, she received both the ASHEcon Willard G. Manning Memorial Award for Best Research in Health Econometrics and the ASA Outstanding Statistical Application Award. She was recently awarded the Open Science Champion Prize by Stanford University. Her research has been featured in The New York Times, USA Today, and The Boston Globe. She was Co-Editor-in-Chief of the journal Biostatistics from 2019-2023. -
Glenn Rosen
Associate Professor of Medicine (Pulmonary and Critical Care Medicine), Emeritus
Current Research and Scholarly InterestsOur laboratory examines apoptotic and cell signaling pathways in cancer and lung disease. We are studying signaling pathways that regulate oxidative stress responses and cancer cell growth. Part of these studies focus on analysis of non-canonical transcription regulatory functions of the TERC and Tert components of telomerase in lung disease and cancer.
-
Michael J Rosen, MD, MSCI
Stanford University Endowed Professor for Pediatric IBD and Celiac Disease
BioDr. Rosen is a pediatric gastroenterologist and physician scientist who has been devoted to advancing inflammatory bowel disease (IBD) research and care for 25 years. He is the inaugural Stanford University Endowed Professor for Pediatric IBD and Celiac Disease. He is also Director of the Stanford Medicine Children’s Health Center for IBD and Celiac Disease, which has achieved nationally leading clinical outcomes under his direction. Dr. Rosen’s research expertise crosses mucosal immunology and epithelial biology and clinical and translational investigation. His NIH-funded laboratory has demonstrated the protective role for type 2 cytokines in chronic intestinal inflammation and advanced intestinal organoids as a model to study IBD. His clinical research has demonstrated how proactive therapeutic drug monitoring can be incorporated into clinical practice to optimize ant-TNF therapy treatment response. Dr. Rosen led the multicenter ARCH Study, which demonstrated the importance of intensified anti-TNF drug dosing in pediatric acute severe ulcerative colitis. Presently, he is co-principal investigator for the Crohn's & Colitis Foundation’s Cohort for Pediatric Translational and Clinical Research in IBD (CAPTURE IBD) which will advance precision medicine for children with IBD.
After graduating from Duke University, Dr. Rosen attended Harvard Medical School, followed by pediatrics residency at Boston Children’s Hospital and Boston Medical Center. He pursued his pediatric gastroenterology fellowship at Vanderbilt University Medical Center, where he received a Master of Science in Clinical Investigation. He started his faculty career at Vanderbilt and then moved to Cincinnati Children’s Hospital and the University of Cincinnati College of Medicine. There he rose to Medical Director of the Schubert Martin IBD Center and Associate Director for Faculty Development in the Gastroenterology division before moving to Stanford in 2021. Dr. Rosen serves on the editorial board for Inflammatory Bowel Diseases and the National Scientific Advisory Committee for the Crohn’s & Colitis Foundation. Outside of work, Dr. Rosen enjoys spending time with his wife and two children at their activities, watching movies, downhill skiing, and getting outside. -
Noah Rosenberg
Stanford Professor of Population Genetics and Society
Current Research and Scholarly InterestsHuman evolutionary genetics, mathematical models in evolution and genetics, mathematical phylogenetics, statistical and computational genetics, theoretical population genetics
-
David Rosenthal
Professor of Pediatrics (Pediatric Cardiology)
Current Research and Scholarly InterestsResearch interests include the study of Heart Failure, Cardiomyopathy and ventricular dysfunction in children, from a clinical perspective. Investigations include clinical trials of medications, cardiac resynchronization, and mechanical circulatory support.
-
Sin Rosenthal
Financial Analyst, Office of Technology Licensing (OTL)
BioSin is responsible for royalty sharing agreements, equity related tasks, billing licensees, aging reports, progress and earned royalty reports, royalty distribution, and special projects that are assigned to her.
-
Jason B. Ross, MD, PhD
Assistant Professor of Radiation Oncology (Radiation Therapy)
Current Research and Scholarly InterestsMy laboratory studies studying normal, dysfunctional, and malignant stem cells in the context of aging, cancer, and cancer therapies.
-
Maya Rossin-Slater
Associate Professor of Health Policy, Senior Fellow at the Stanford Institute for Economic Policy Research and Associate Professor, by courtesy, of Economics
Current Research and Scholarly InterestsHealth and public economics; public policy; families; health disparities
-
Gregory Rosston
Gordon Cain Senior Fellow at the Stanford Institute for Economic Policy Research
BioGreg Rosston is Director of the Public Policy program at Stanford University, the Gordon Cain Senior Fellow at the Stanford Institute for Economic Policy Research, and Professor of Economics (by courtesy). He teaches Economics and Public Policy courses on competition policy and strategy, economic policy analysis, and writing and rhetoric.
Dr. Rosston served as Deputy Chief Economist at the Federal Communications Commission working on the implementation of the Telecommunications Act of 1996 and the design and implementation of the first ever spectrum auctions in the United States. In 2011, he was Senior Economist for Transactions for the Federal Communications Commission for the proposed AT&T – T-Mobile transaction. He served as a member and co-chair of the Department of Commerce Spectrum Management Advisory Committee.
Dr. Rosston received his Ph.D. in Economics from Stanford University and his A.B. with Honors from the University of California at Berkeley. Dr. Rosston has written extensively on the application of economics to telecommunications and competition issues. He has advised companies and governments regarding auctions and served as a consultant to various organizations including the World Bank and the Federal Communications Commission, and as a board member and advisor to high technology, financial, and startup companies. He serves as Vice Chair of the Board of the Stanford Federal Credit Union, as a Board member of the Nepal Youth Foundation and as an Advisory Board member of Sustainable Conservation and the Technology Policy Institute. -
Stephen J. Roth
Professor of Pediatrics (Cardiology), Emeritus
Current Research and Scholarly InterestsRandomized Therapeutic Trials in Pediatric Heart Disease, NIH/U01 GrantNo. HL68285 2001-2006.
Heparin and the Reduction of Thrombosis (HART) Study. Pediatric Health Research Fund Award, Stanford Univ Sch of Medicine, 2005-2006.
A Pilot Trial fo B-type Natriuretic Peptide for Promotion of Urine Output in Diuretic-Resistant Infants Following Cardiovascular Surgery.Pediatric Health Research Fund Award, Stanford Univ Sch of Medicine, 2005-2006. -
Theodore Roth
Assistant Professor of Pathology
Current Research and Scholarly InterestsThe Roth Lab develops, applies, and translates scalable genetic manipulation technologies in primary human cells and complex in vivo tissue environments. Working with students, trainees, and staff with backgrounds across bioengineering, genetics, immunology, oncology, and pathology, the lab has developed CRISPR-All, a unified genetic perturbation language able to arbitrarily and combinatorially examine genetic perturbations across perturbation type and scale in primary human cells. Ongoing applications of CRISPR-All in the lab have revealed surprising capacities to synthetically engineer human cells beyond evolved cellular states. These new capacities to perturb human cell’s genetics beyond their evolved functionality drives ongoing work to understand the biology and therapeutic potential of synthetic cell state engineering - in essence learning how to build new human genes tailor made for a specific cell and specific environment to drive previously inaccessible therapeutic cellular functions.
-
Grant M. Rotskoff
Assistant Professor of Chemistry
BioGrant Rotskoff studies the nonequilibrium dynamics of living matter with a particular focus on self-organization from the molecular to the cellular scale. His work involves developing theoretical and computational tools that can probe and predict the properties of physical systems driven away from equilibrium. Recently, he has focused on characterizing and designing physically accurate machine learning techniques for biophysical modeling. Prior to his current position, Grant was a James S. McDonnell Fellow working at the Courant Institute of Mathematical Sciences at New York University. He completed his Ph.D. at the University of California, Berkeley in the Biophysics graduate group supported by an NSF Graduate Research Fellowship. His thesis, which was advised by Phillip Geissler and Gavin Crooks, developed theoretical tools for understanding nonequilibrium control of the small, fluctuating systems, such as those encountered in molecular biophysics. He also worked on coarsegrained models of the hydrophobic effect and self-assembly. Grant received an S.B. in Mathematics from the University of Chicago, where he became interested in biophysics as an undergraduate while working on free energy methods for large-scale molecular dynamics simulations.
Research Summary
My research focuses on theoretical and computational approaches to "mesoscale" biophysics. Many of the cellular phenomena that we consider the hallmarks of living systems occur at the scale of hundreds or thousands of proteins. Processes like the self-assembly of organelle-sized structures, the dynamics of cell division, and the transduction of signals from the environment to the machinery of the cell are not macroscopic phenomena—they are the result of a fluctuating, nonequilibrium dynamics. Experimentally probing mesoscale systems remains extremely difficult, though it is continuing to benefit from advances in cryo-electron microscopy and super-resolution imaging, among many other techniques. Predictive and explanatory models that resolve the essential physics at these intermediate scales have the power to both aid and enrich the understanding we are presently deriving from these experimental developments.
Major parts of my research include:
1. Dynamics of mesoscale biophysical assembly and response.— Biophysical processes involve chemical gradients and time-dependent external signals. These inherently nonequilibrium stimuli drive supermolecular organization within the cell. We develop models of active assembly processes and protein-membrane interactions as a foundation for the broad goal of characterizing the properties of nonequilibrium biomaterials.
2. Machine learning and dimensionality reduction for physical models.— Machine learning techniques are rapidly becoming a central statistical tool in all domains of scientific research. We apply machine learning techniques to sampling problems that arise in computational chemistry and develop approaches for systematically coarse-graining physical models. Recently, we have also been exploring reinforcement learning in the context of nonequilibrium control problems.
3. Methods for nonequilibrium simulation, optimization, and control.— We lack well-established theoretical frameworks for describing nonequilibrium states, even seemingly simple situations in which there are chemical or thermal gradients. Additionally, there are limited tools for predicting the response of nonequilibrium systems to external perturbations, even when the perturbations are small. Both of these problems pose key technical challenges for a theory of active biomaterials. We work on optimal control, nonequilibrium statistical mechanics, and simulation methodology, with a particular interest in developing techniques for importance sampling configurations from nonequilibrium ensembles. -
Scott Rozelle
Helen C. Farnsworth Professor of International Agricultural Policy and Senior Fellow at the Stanford Institute for Economic Policy Research
Current Research and Scholarly InterestsThemes related to China, especially agricultural policy, the emergence and evolution of markets and other economic institutions, and the economics of poverty and inequality.
-
Daniel Rubin
Professor of Biomedical Data Science and of Radiology (Integrative Biomedical Imaging Informatics at Stanford), Emeritus
Current Research and Scholarly InterestsMy research interest is imaging informatics--ways computers can work with images to leverage their rich information content and to help physicians use images to guide personalized care. Work in our lab thus lies at the intersection of biomedical informatics and imaging science.
-
Sam Rubin
Licensing Manager, Life Sciences, Office of Technology Licensing (OTL)
BioSam Joined OTL in September 2022 as a Licensing Associate on the Life Sciences team. Prior to joining, Sam worked in various business-focused roles in the life science industry. He has experience negotiating and executing services agreements for complex drug development collaborations, as well as technology licensing agreements with industry partners.
-
Daniel Rugar
Affiliate, Ginzton, E.L. Laboratory
Visiting Scholar, Ginzton, E.L. LaboratoryBioDaniel Rugar is visiting scholar at Stanford University working with Professor Amir Safavi-Naeini. He retired from IBM Research in 2024, finishing as Principal Research Scientist and Manager of Exploratory Quantum Devices at the IBM Almaden Research Center in San Jose, California. He previously served as an IBM Distinguished Research Staff Member and Manager of Nanoscale Studies.
Dr. Rugar received his B.A. in Physics from Pomona College in 1975 and his Ph.D. in Applied Physics from Stanford University in 1982. He was co-recipient of the Günther Laukien Prize for the development of magnetic resonance force microscopy and was awarded the Cozzarelli Prize from the Proceedings of the National Acacademy of Sciences. He has served as a Distinguished Lecturer of the IEEE Magnetic Society. More recently, he was awarded the 2022 APS Keithley Award in Measurement Science. Dr. Rugar is a fellow of the American Physical Society (APS), the American Association for the Advancement of Science (AAAS) and the Institute of Electrical and Electronic Engineers (IEEE). -
Ahmad Rushdi
Director of Industry Programs, Institute for Human-Centered Artificial Intelligence (HAI)
BioAhmad A. Rushdi, PhD, is the director of HAI industry programs—research collaborations and executive education—at Stanford’s Institute for Human-Centered AI (HAI), translating cutting-edge research into responsible, deployable solutions for global enterprises. He forges durable bridges between Stanford scholars and industry to advance trustworthy, real-world AI.
Ahmad's own research focuses on uncertainty quantification and statistical signal processing for AI/ML systems. Previously, he held R&D roles at Sandia National Labs, Northrop Grumman, UC Davis, UT Austin, and Cisco. He earned a PhD in Electrical & Computer Engineering from UC Davis and MS/BS degrees in Electrical Engineering from Cairo University. -
Mirabela Rusu
Assistant Professor of Radiology (Integrative Biomedical Imaging Informatics) and, by courtesy, of Biomedical Data Science and of Urology
Current Research and Scholarly InterestsDr. Mirabela Rusu focuses on developing analytic methods for biomedical data integration, with a particular interest in radiology-pathology fusion. Such integrative methods may be applied to create comprehensive multi-scale representations of biomedical processes and pathological conditions, thus enabling their in-depth characterization.
-
Florentine Rutaganira
Assistant Professor of Biochemistry and of Developmental Biology
Current Research and Scholarly InterestsWe use chemical tools to decipher the roles of key signaling networks in choanoflagellates, single-celled organisms that are the closest living relatives of animals. Choanoflagellates produce molecular signals essential for intercellular communication in animals and the presence of these molecules in choanoflagellates suggests that signaling components needed to communicate between cells is evolutionarily ancient. We aim to uncover new understanding of animal development, physiology and disease.
-
Brian Rutt
Professor of Radiology (Radiological Sciences Lab), Emeritus
Current Research and Scholarly InterestsMy research interests center on MRI research, including high-field and high-resolution MRI technology development as well as applications of advanced MRI techniques to studying the brain, cardiovascular system and cancer.
-
Matthew Ryan
Licensing Manager, Physical Sciences, Office of Technology Licensing (OTL)
BioMatthew joined Stanford's Office of Technology Licensing (OTL) in 2025 as a Licensing Manager, Physical Sciences. Previously, Matthew co-founded a venture backed startup and brings experience in licensing, partnership development, and hardtech/deeptech commercialization.
